ESTRO 2024

Join our LIVE Lunch Symposium

on Monday May 6th in Glasgow.

Welcome to the Boston Scientific hub dedicated to ESTRO 2024 Congress - taking place this year at the Scottish Events Campus Glasgow (UK), from May 3rd to May 7th. Our team will be present at Booth #450 to support you and your practice in advancing prostate cancer radiation therapy together with SpaceOARTM Hydrogel.

Elevate your expertise by attending our Live Symposium

'Let’s talk evidence. The journey of prostate radiation therapy with SpaceOARTM Hydrogel. Physician's perspectives on best practice when treating today’s patient.’

Date: Monday, May 6th

Time: 1pm – 2pm local time

Location: Hall 1


Our European expert panel will journey through the evolution of prostate radiation therapy, speaking to the evidence for SpaceOARTM Hydrogel use and their clinical experiences.

What can you expect at our booth?

Step into the world of SpaceOARTM Hydrogel at Booth #450. Learn about SpaceOAR VueTM Hydrogel and engage with our experts. From interactive demonstrations to insightful discussions, there is something for everyone:

• A procedural simulator session to navigate the procedure step by step

Product demonstrations to get hands on with SpaceOARTM Hydrogel and SpaceOAR VueTM Hydrogel

• An area dedicated to clinical evidence on SpaceOARTM Hydrogel and SpaceOAR VueTM Hydrogel

• Your favourite coffee from the coffee bar and much more.

See you there.

Your local Boston Scientific Representative awaits you.


IMPORTANT INFORMATION: SpaceOAR and SpaceOAR Vue Hydrogels are intended to temporarily position the anterior rectal wall away from the prostate during radiotherapy for prostate cancer and in creating this space it is the intent of SpaceOAR and SpaceOAR Vue Hydrogels to reduce the radiation dose delivered to the anterior rectum. SpaceOAR and SpaceOAR Vue Hydrogels contain Polyethylene Glycol (PEG). SpaceOAR Vue Hydrogel contains iodine. Prior to using these devices, please review the Instructions for Use for a complete listing of indications, contraindications, warnings, precautions and potential adverse events.As with any medical treatment, there are some risks involved with the use of SpaceOAR and SpaceOAR Vue Hydrogels. Potential complications associated with SpaceOAR and SpaceOAR Vue Hydrogels include, but are not limited to: pain associated with SpaceOAR and SpaceOAR Vue Hydrogels injection, pain ordiscomfort associated with SpaceOAR and SpaceOAR Vue Hydrogels, local inflammatory reactions, infection (including abscess), urinary retention, urgency, constipation (acute, chronic, or secondary to outlet perforation), rectal tenesmus/muscle spasm, mucosal damage, ulcers, fistula, perforation (including prostate, bladder, urethra, rectum), necrosis, allergic reaction (localized or more severe reaction, such as anaphylaxis), embolism (venous or arterial embolism is possible and may present outside of the pelvis, potentially impacting vital organs or extremities), syncope and bleeding. The occurrence of one or more of these complications may require treatment or surgical intervention.URO- 989811-AB MAR 2022

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, Contraindications, warnings and instructions for use can be found in the product labelling supplied with each device. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.2024 Copyright © Boston Scientific Corporation or its affiliates. All rights reserved.